Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Elevated levels of soluble ST2 protein in dengue virus infected patients.

Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I.

Cytokine. 2008 Feb;41(2):114-20. doi: 10.1016/j.cyto.2007.11.001.

2.

High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.

Guerrero CD, Arrieta AF, Ramirez ND, Rodríguez LS, Vega R, Bosch I, Rodríguez JA, Narváez CF, Salgado DM.

Cytokine. 2013 Mar;61(3):766-71. doi: 10.1016/j.cyto.2012.12.024.

PMID:
23357301
3.

Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.

Houghton-Triviño N, Salgado DM, Rodríguez JA, Bosch I, Castellanos JE.

J Gen Virol. 2010 Mar;91(Pt 3):697-706. doi: 10.1099/vir.0.012971-0.

PMID:
19889931
4.

Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.

Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, van 't Veer C, van Gorp EC.

PLoS Negl Trop Dis. 2009 Jun 2;3(6):e453. doi: 10.1371/journal.pntd.0000453.

5.

Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.

Kim DJ, Baek SY, Park MK, Park KS, Lee JH, Park SH, Kim HY, Kwok SK.

J Korean Med Sci. 2013 Aug;28(8):1145-53. doi: 10.3346/jkms.2013.28.8.1145.

6.

Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.

Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.

Cytokine. 2013 May;62(2):272-7. doi: 10.1016/j.cyto.2013.03.007.

PMID:
23561929
7.

Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.

Bao YS, Na SP, Zhang P, Jia XB, Liu RC, Yu CY, Mu SH, Xie RJ.

J Clin Immunol. 2012 Jun;32(3):587-94. doi: 10.1007/s10875-011-9622-7.

PMID:
22203232
8.

Status of soluble ST2 levels in serum of HTLV-1 infected individuals.

Zahedi Avval F, Shomali S, Nadri M, Boostani R, Jarahi L, Youssefi M.

Acta Microbiol Immunol Hung. 2015 Jun;62(2):137-45. doi: 10.1556/030.62.2015.2.4.

PMID:
26132834
9.

IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.

Zhang Y, Zhang C, Zhuang R, Ma Y, Zhang Y, Yi J, Yang A, Jin B.

PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003514. doi: 10.1371/journal.pntd.0003514.

10.

Serum soluble ST2 is associated with ER-positive breast cancer.

Lu DP, Zhou XY, Yao LT, Liu CG, Ma W, Jin F, Wu YF.

BMC Cancer. 2014 Mar 18;14:198. doi: 10.1186/1471-2407-14-198.

11.

Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.

Hladinova Z, Hruskova Z, Svobodova B, Malickova K, Lanska V, Konopásek P, Jancova E, Rysava R, Edelstein CL, Tesar V.

Mediators Inflamm. 2015;2015:603750. doi: 10.1155/2015/603750.

12.

The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.

Wakatabi K, Komine M, Meephansan J, Matsuyama Y, Tsuda H, Tominaga S, Ohtsuki M.

Eur J Dermatol. 2012 May-Jun;22(3):333-6. doi: 10.1684/ejd.2012.1706.

PMID:
22494834
13.

Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.

Lin CY, Pfluger CM, Henderson RD, McCombe PA.

J Neuroimmunol. 2012 Aug 15;249(1-2):93-5. doi: 10.1016/j.jneuroim.2012.05.001.

PMID:
22633272
14.

Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.

Vivanco-Cid H, Maldonado-Rentería MJ, Sánchez-Vargas LA, Izaguirre-Hernández IY, Hernández-Flores KG, Remes-Ruiz R.

Immunol Lett. 2014 Sep;161(1):89-95. doi: 10.1016/j.imlet.2014.05.006.

15.

Soluble ST2 plasma concentrations predict mortality in severe sepsis.

Hoogerwerf JJ, Tanck MW, van Zoelen MA, Wittebole X, Laterre PF, van der Poll T.

Intensive Care Med. 2010 Apr;36(4):630-7. doi: 10.1007/s00134-010-1773-0.

16.

Establishment of reference intervals for soluble ST2 from a United States population.

Lu J, Snider JV, Grenache DG.

Clin Chim Acta. 2010 Nov 11;411(21-22):1825-6. doi: 10.1016/j.cca.2010.07.014.

PMID:
20654603
17.

Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.

Roth GA, Zimmermann M, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG, Ankersmit HJ.

J Surg Res. 2010 Oct;163(2):e79-83. doi: 10.1016/j.jss.2010.04.004.

PMID:
20638676
18.

Temporal changes of soluble ST2 after cardiovascular interventions.

Willems S, Sels JW, Flier S, Versteeg D, Buhre WF, de Kleijn DP, Hoefer IE, Pasterkamp G.

Eur J Clin Invest. 2013 Feb;43(2):113-20. doi: 10.1111/eci.12022.

PMID:
23215810
19.

Investigations into the role of ST2 in acute asthma in children.

Ali M, Zhang G, Thomas WR, McLean CJ, Bizzintino JA, Laing IA, Martin AC, Goldblatt J, Le Souëf PN, Hayden CM.

Tissue Antigens. 2009 Mar;73(3):206-12. doi: 10.1111/j.1399-0039.2008.01185.x.

PMID:
19254249
20.

Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome.

Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, Chuansumrit A.

Pediatr Infect Dis J. 2006 Oct;25(10):894-7.

PMID:
17006283

Supplemental Content

Support Center